BRIEF published on 07/22/2025 at 09:05, 8 months 25 days ago Gut Microbiome: A Potential Early Indicator of Dementia Risk Early Detection Screening Tools Gut Microbiome Dementia Risk MCI Prediction
PRESS RELEASE published on 07/22/2025 at 09:00, 8 months 25 days ago Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk Study reveals gut microbiome may offer early insight into dementia risk, potentially leading to screening tools for routine diagnostics and early interventions. SYNLAB expert co-authors findings Alzheimer's Disease Early Detection SYNLAB Gut Microbiome Dementia Risk
BRIEF published on 07/01/2025 at 09:05, 9 months 15 days ago VαMPiRE Project Makes Strides in Parkinson’s Detection EU Funding Parkinson’s Detection VαMPiRE Project SYNLAB Diagnostics Α-synuclein Biomarkers
PRESS RELEASE published on 07/01/2025 at 09:00, 9 months 15 days ago Milestone Reached in Groundbreaking Project for Early Detection of Parkinson’s Disease SYNLAB reaches a milestone in the VαMPiRE project funded by the EU, focusing on early Parkinson's disease detection with advanced genomics and €8 million funding Parkinson's Disease Diagnostic Test EU Funding SYNLAB VαMPiRE Project
BRIEF published on 10/30/2024 at 07:37, 1 year 5 months ago Cinven Acquires Elliott's Stake in SYNLAB AG with Squeeze-Out Imminent Private Equity Squeeze-out SYNLAB AG Cinven Elliott Advisors
PRESS RELEASE published on 10/30/2024 at 07:32, 1 year 5 months ago Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow Cinven acquires Elliott's stake in SYNLAB AG, squeeze-out procedure initiated. SYNLAB's Management Board informed. Ephios Bidco to hold over 96% share capital Private Equity SYNLAB AG Cinven Elliott Squeeze Out
BRIEF published on 09/17/2024 at 16:05, 1 year 6 months ago Cinven to Sell Minority Stake in SYNLAB to Labcorp Investment SYNLAB Cinven Labcorp Minority Stake
PRESS RELEASE published on 09/17/2024 at 16:00, 1 year 6 months ago Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Cinven agrees to sell 15% stake in SYNLAB to Labcorp, a global leader in laboratory services. Transaction aims to enhance lab efficiency and customer experience Strategic Investor Medical Diagnostics SYNLAB Cinven Labcorp
BRIEF published on 06/04/2024 at 20:51, 1 year 10 months ago Cybersecurity Incident at Synnovis in UK Cybersecurity SYNLAB Synnovis NHS England Impact
PRESS RELEASE published on 06/04/2024 at 20:46, 1 year 10 months ago Cybersecurity Incident at Synnovis in UK SYNLAB AG confirms cybersecurity incident at Synnovis in the UK, isolated from previous attacks. Taskforce working to assess impact and minimize disruptions for patients and partners SYNLAB AG Synnovis NHS England Cybersecurity Incident Patient Impact
Published on 04/17/2026 at 02:13, 1 hour 10 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 1 hour 23 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 3 hours 51 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 5 hours 53 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 23:40, 3 hours 43 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 5 hours 46 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 6 hours 23 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 6 hours 48 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 8 hours 5 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 9 hours 21 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 9 hours 29 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
